Effect of garlic supplement in the management of type 2 diabetes mellitus (T2DM): a meta-analysis of randomized controlled trials

References

• Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–9.
   PubMed Web of Science ®Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.
   PubMed Web of Science ®Google Scholar
• Semenkovich K, Brown ME, Svrakic DM, et al. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015;75(6):577–587.
   PubMed Web of Science ®Google Scholar
• Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12(4):288–298.
   Web of Science ®Google Scholar
• Association AD. Executive summary: standards of medical care in diabetes–2014. Diabetes Care. 2014;37 S1(2):S4–S10.
   Google Scholar
• Corzo-Martínez MCN. Biological properties of onions and garlic. Trends Food Sci Technol. 2007;18(12):609–625.
   Web of Science ®Google Scholar
• Santhosha SG, Jamuna P, Prabhavathi SN. Bioactive components of garlic and their physiological role in health maintenance: A review. Food Biosci. 2013;3(2013):59–74.
   Google Scholar
• Tejani A. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients: summaries of nursing care-related systematic reviews from the cochrane library. Cochrane Database Syst Rev. 2013;11(1):CD007653.
   Google Scholar
• Schwingshackl L, Missbach B, Hoffmann G. An umbrella review of garlic intake and risk of cardiovascular disease. Phytomedicine. 2015. DOI:10.1016/j.phymed.2015.10.015
   Web of Science ®Google Scholar
• Chiavarini M, Minelli L, Fabiani R. Garlic consumption and colorectal cancer risk in man: a systematic review and meta-analysis. Public Health Nutr. 2015;19(2):308–317.
   Web of Science ®Google Scholar
• Ashraf R, Aamir K, Shaikh AR, et al. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J Ayub Med Coll Abbottabad. 2005;17(3):60–64.
   PubMedGoogle Scholar
• Sobenin IA, Nedosugova LV, Filatova LV, et al. Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study. Acta Diabetol. 2008;45(1):1–6.
   PubMed Web of Science ®Google Scholar
• Sukandar EY, Permana H, Adnyana IK, et al. Clinical study of turmeric (Curcuma longa L.) and garlic (Allium sativum L.) extracts as antihyperglycemic and antihyperlipidemic agent in type-2 diabetes-dyslipidemia patients. Int J Pharmacol. 2010;6(4):456–463.
   Google Scholar
• Ashraf R, Khan RA, Ashraf I. Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients. Pak J Pharm Sci. 2011;24(4):565–570.
   PubMed Web of Science ®Google Scholar
• Ashraf R, Khan RA, Ashraf I. Effects of garlic on blood glucose levels and HbA1c in patients with type 2 diabetes mellitus. J Med Plants Res. 2011;5(13):2922–2928.
   Google Scholar
• Song AL, Song HF, Xiao YH, et al. Changes of plasma hs-CRP and C-peptide In T2DM patients after garlic and insulin combination therapy. Chin J Clin Rehabil. 2006;10(9):122.
   Google Scholar
• Chhatwal S, Sharma RK, Sharma G, et al. To study the antihyperglycaemic and lipid lowering effect of garlic as an adjunct to metformin in patients of type 2 diabetes mellitus with obesity. Int J Basic Clin Pharmacol. 2012;1(1):22–26.
   Google Scholar
• Kumar R, Chhatwal S, Arora S, et al. Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes Metab Syndr Obes. 2013;6:49.
   PubMedGoogle Scholar
• Manafikhi R, Kalie L, Lahdo R. Effects of garlic supplementation on fasting blood sugar, HbA1c and lipid profile in type 2 diabetics receiving metformin and glyburide. Int J Acad Scientific Res. 2015;3(5):11–18.
   Google Scholar
• Atkin M, Laight D, Cummings MH. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial. J Diabetes Complications. 2016;30:723–727.
   Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343(10):d5928.
   Google Scholar
• Padiya R, Banerjee SK. Garlic as an anti-diabetic agent: recent progress and patent reviews. Recent Pat Food. 2013;5(2):105–127.
   PubMedGoogle Scholar
• Banerjee SK, Mukherjee PK, Maulik SK. Garlic as an antioxidant: the good, the bad and the ugly. Phytotherapy Res. 2003;17(2):97–106.
   PubMed Web of Science ®Google Scholar
• Hughes BG, Lawson LD. Antimicrobial effects of Allium sativum L. (garlic), Allium ampeloprasum L. (elephant garlic), and Allium cepa L. (onion), garlic compounds and commercial garlic supplement products. Phytotherapy Res. 1991;5(4):154–158.
   Web of Science ®Google Scholar
• Jain RC, Vyas CR. Garlic in alloxan-induced diabetic rabbits. Am J Clin Nutr. 1975;28(7):684–685.
   Web of Science ®Google Scholar
• Padiya R, Khatua TN, Bagul PK, et al. Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats. Nutr Metab. 2011;8(1):53.
   Google Scholar
• Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. Jama J Am Med Assoc. 2013;309(21):2240–2249.
   PubMed Web of Science ®Google Scholar
• Sahebkar A, Serban C, Ursoniu S, et al. Effect of garlic on plasma lipoprotein (a) concentrations: a systematic review and meta-analysis of randomized controlled clinical trials. Nutrition. 2016;32(1):33–40.
   Web of Science ®Google Scholar
• Toth PP. High-density lipoprotein and cardiovascular risk. Circulation. 2004;109(15):1809–1812.
   PubMed Web of Science ®Google Scholar